SancyALeachmanMD, PhD, FAAD
Dermatology • Portland, ORDermatologic Surgery
Professor, Dermatology, Oregon Health & Science University
Dr. Leachman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3303 SW Bond Ave
Suite 16D
Portland, OR 97239Phone+1 503-494-6024- Is this information wrong?
Summary
- I am a Board Certified Dermatologist specializing in the care of Melanoma with a sub-specialty in familial/hereditary melanoma and melanoma genetics. I am the Principal Investigator for the War On Melanoma, a melanoma early detection program. I am also Chair of the Department of Dermatology and Director of the Melanoma and Skin Cancer Program at Knight Cancer Institute at Oregon Health and Science University.
Education & Training
Yale-New Haven Medical CenterResidency, Dermatology, 1994 - 1997
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1993 - 1994
University of Texas Southwestern Medical SchoolClass of 1993
Certifications & Licensure
FL State Medical License 2020 - Present
UT State Medical License 1998 - 2026
OR State Medical License 2013 - 2025
TX State Medical License 1994 - 2025
CT State Medical License 1997 - 1999- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- John D. Gray Endowed Chair in Melanoma Research Knight Cancer Institute at OHSU
- Career Achievement Award & Aaron Lerner Lectureship Pan American Society for Pigment Cell Research, 2021
- Top Doctor Portland Monthly, 2017-2021
- Join now to see all
Clinical Trials
- Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita Start of enrollment: 2008 Jan 01
- At-Home Dermoscopy Artificial Intelligence Start of enrollment: 2024 Jan 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Increase in melanoma knowledge in Latino patients after a targeted digital educational program.Greene, A., Iloabuchi, V., Stoos, E., Butterfield, R., Zhang, N., Mangold, A., Leachman, S., Costello, C.> ;JAAD International. 2024 Mar 1
- Evidence-Based Communication to Increase Melanoma Knowledge and Skin Checks.Nadratowski, A., Shoots-Reinhard, B., Shafer, A., Detweiler-Bedell, J., Detweiler-Bedell, B., Peters, E., Leachman, S.> ;JID Innovations. 2024 Mar 1
- Microbes, Autoimmunity, and Cancer: 69th Annual Montagna Symposium on the Biology of Skin.O'Shea, J., Roop, D., Modlin, R., Anandasabapathy, N., Kaplan, D., Leachman, S.> ;The Journal of Investigative Dermatology. 2024 Jan 31
- Join now to see all
Journal Articles
- Dermoscopy Proficiency Expectations for US Dermatology Resident PhysiciansLaura K Ferris, Natalia Jaimes, John C Kawaoka, Caroline C Kim, Sancy A Leachman, Patricia Lucey, Michael A Marchetti, Ashfaq A Marghoob, Edward Prodanovic, Elizabeth ..., JAMA Dermatology
- Prognostic Gene Expression Profiling in Cutaneous MelanomaDouglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology
Lectures
- Melanoma: The Future is NowAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- In Vitro Behavior and UV Response of Melanocytes Derived from Carriers of CDKN2A Mutations and MC1R VariantsAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 2/28/2019
Authored Content
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Press Mentions
OHSU Dermatologists Set New Record for Finding Smallest Skin CancerMay 19th, 2023- OHSU Dermatologists Detect the World’s Smallest Skin CancerMay 1st, 2023
- Hottest Topics of the 2023 AAD Annual MeetingMarch 27th, 2023
- Join now to see all
Grant Support
- Impact Of Melanoma Genetic Testing On Health Cognitions And Prevention BehaviorsNational Cancer Institute2011–2012
- Impact Of MC1R Functional Variants On The DNA Damage Response Of Human MelanocyteNational Institute Of Environmental Health Sciences2009–2012
- Phase IB Trial Of Td101 Sirna For Pachyonychia Congenita (Ind 77,504, 12-03-07)Food And Drug Administration2008–2009
- Familial Melanoma Research Clinic (FMRC)National Center For Research Resources2004–2008
Research History
- Director, Melanoma & Skin Cancer Research ProgramDr. Leachman’s career has been devoted to the application of science to medicine, particularly molecular genetics. Her focus has been on human genetic skin disorders and melanoma. She has incorporated methods and tools across basic and clinical science, population science and public health.2013 - Present
Professional Memberships
- Fellow
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
OHSU HospitalPortland, Oregon
External Links
- Home pagehttps://www.ohsu.edu/providers/sancy-leachman-md-phd
- WarOnMelanomahttps://www.ohsu.edu/war-on-melanoma
- StartSeeingMelanomahttps://startseeingmelanoma.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
